In October, HSA gave Tychan the green light to start final-stage trials. - TYCHAN
SINGAPORE (The Straits Times/ANN): The final phase of the clinical trial for a Covid-19 antibody developed by Singapore biotechnology company Tychan began on Friday (Dec 11).
The antibody can potentially help patients with the coronavirus to recover faster, while slowing the progression of the infection.
Some 1,305 patients who have tested positive for Covid-19 will take part voluntarily in the clinical trials.
If the clinical trials are successful, the antibody will be submitted for review by the Health Sciences Authority (HSA) and other regulatory agencies as a new drug.
SINGAPORE (The Straits Times/ANN): South-east Asia's largest bank DBS will launch a digital currency exchange that will allow investors to trade in cryptocurrencies and firms to raise funds through asset tokenisation
SINGAPORE (The Straits Times/ANN): With the spectre of Disease X looming, Singapore is making sure that diagnostics, treatments and vaccines will be ready fast when another crisis strikes, with a new battle plan against future outbreaks.
SINGAPORE (The Straits Times/ANN): A managing director and his Singapore-based wholesale trading company unlawfully supplied goods mainly wines and spirits worth more than S$745,000 to North Korea between 2013 and 2018.
7:05 PM MYT
CTi s TV host records a news programme in front of their office building in Taipei, Taiwanon Dec 10, 2020. - Reuters
TAIPEI (The Straits Times/ANN): A pro-China cable TV station has been taken off air after Taiwan s media regulator found it had failed to address findings of bias and disinformation.
Chung T ien Television (CTi) was removed from the cable TV network in Taiwan on Friday (Dec 11), the day its licence expired.
Prior to going off-air, CTi which was among Taiwan s most-watched cable news stations - put out a 42-hour marathon live broadcast of its anchors and hosts chatting about their experiences working for CTi, and its 26 years of broadcast history.